Oncternal Therapeutics Email Formats

Biotechnology Research • San Diego, California, United States • 1-10 Employees

Oncternal Therapeutics Email Formats

Oncternal Therapeutics uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@oncternal.com), used 85.7% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@oncternal.com	85.7%
{first name}{last name}	johndoe@oncternal.com	14.3%

Key Contact at Oncternal Therapeutics

Ariadne Jerue

A. Director - Clinical Operations

Company overview

Headquarters	12230 El Camino Real, Suite 300, San Diego, California 92130, US
Phone number	+105917470
Website	oncternal.com
SIC	283
Founded	2013
Employees	1-10
Socials

About Oncternal Therapeutics

Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need. Oncternal focuses drug development on promising yet untapped biological pathways implicated in cancer progression. The pipeline includes cirmtuzumab, a monoclonal antibody in Phase 1/2 development that inhibits the ROR1 receptor in various hematologic cancers; TK-216, a small-molecule in Phase 1 development that inhibits ETS-family oncoproteins, as a treatment for Ewing sarcoma, a rare pediatric cancer; and a CAR-T therapy that targets ROR1 currently in preclinical development as a potential treatment for solid tumors and hematologic cancers. Based in San Diego, Oncternal is committed to advancing its pipeline rapidly and efficiently to bring patients a new wave of first-in-class cancer treatments.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Vice President

C-Suite

Director

Employees by Department

Oncternal Therapeutics has 4 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore Oncternal Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-01-09	14	$86,200,000

Funding Insights

$86,200,000

Total funding amount

$86,200,000

Most recent funding amount

Number of funding rounds

Oncternal Therapeutics Tech Stack

Discover the technologies and tools that power Oncternal Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Modernizr

JavaScript libraries

Cloudflare Bot Management

Security

Ninja Forms

Form builders

Marionette.js

JavaScript frameworks

Underscore.js

JavaScript libraries

PWA

Miscellaneous

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

PHP

Programming languages

Frequently asked questions

Oncternal Therapeutics is located in San Diego, California, US.

You can reach Oncternal Therapeutics at +105917470.

Oncternal Therapeutics was founded in 2013, making it 13 years old. The company has established itself as a significant player in its industry over this time.

Oncternal Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Oncternal Therapeutics has raised a total of $86,200,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Oncternal Therapeutics

Ariadne Jerue

A. Director - Clinical Operations

4.8

40,000 users